195
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital’s Patients, Egypt: A Retrospective Study

, ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 2375-2383 | Published online: 17 Jul 2020

References

  • Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClin Med. 2020;21:100331. doi:10.1016/j.eclinm.2020.100331
  • WHO. WHO director-general’s remarks at the media briefing on SARS-CoV2 on 16 March 2020; 2020 Available from: http://www.nhc.gov.cn/xcs/yqfkdt/202003/114113d25c1d47aabe68381e836f06a8.shtml
  • Alzoubi H, Alnawaiseh N, Al-Mnayyis A, Abu- Lubada M, Aqel A, Al-Shagahin H. COVID-19 - knowledge, attitude and practice among medical and non-medical university students in jordan. J Pure Appl Microbiol. 2020;14(1):17–24. doi:10.22207/JPAM.14.1.04
  • Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X32085846
  • WHO. COVID-2019 situation report—26. 2020 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200215-sitrep-26-covid-19.pdf?sfvrsn=a4cc6787_2. (accessed 331, 2020).
  • Hassany M, Abdel-Razek W, Asem N, AbdAllah M, Zaid H. Estimation of COVID-19 burden in Egypt. Lancet Infect Dis. 2020. doi:10.1016/S1473-3099(20)30319-4
  • Wang YY, Jin YH, Ren XQ, et al. Updating the diagnostic criteria of COVID-19 “suspected case” and “confirmed case” is necessary. Mil Med Res. 2020;7(1):17. doi:10.1186/s40779-020-00245-932245396
  • Li L, Li R, Wu Z, et al. Therapeutic strategies for critically ill patients with COVID-19. Ann Intensive Care. 2020;10(1):45. doi:10.1186/s13613-020-00661-z32307593
  • Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26(6):767–772. doi:10.1016/j.cmi.2020.04.01232304745
  • Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020. doi:10.1016/j.jinf.2020.03.005
  • Mahase E. Covid-19: death rate is 0.66% and increases with age, study estimates. BMJ. 2020;369:m1327. doi:10.1136/bmj.m132732238354
  • Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.01732173574
  • Zhou F, Yu T, Du R, Fan G, Liu Y. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054e62. doi:10.1016/S0140-6736(20)30566-332171076
  • Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.32232218
  • Marhl M, Grubelnik V, Magdič M, Markovič R. Diabetes and metabolic syndrome as risk factors for COVID-19. Diabetes Metab Syndr. 2020;14(4):671–677. doi:10.1016/j.dsx.2020.05.01332438331
  • Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303–310. doi:10.1016/j.dsx.2020.04.00432298981
  • Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and Smoking in patients with COVID-19: A rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.023314732392262
  • Cai G, Cui X, Zhu X, Zhou J. A Hint on the COVID-19 Risk: population disparities in gene expression of three receptors of SARS-CoV. 2020.
  • Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18(March):20. doi:10.18332/tid/11932432206052
  • Guan GW, Gao L, Wang JW, et al. Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia. Zhonghua Gan Zang Bing Za Zhi. 2020;28(2):100–106. doi:10.3760/cma.j.issn.1007-3418.2020.02.00232077659
  • Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-931986261
  • Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.. JAMA. 2020;323(11):1061. doi:10.1001/jama.2020.1585
  • Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020. doi:10.1016/j.jinf.2020.04.021
  • Shi L, Wang Y, Wang Y, Duan G, Yang H. Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19. J Infect. 2020. doi:10.1016/j.jinf.2020.05.013
  • Li Y, Coronavirus Disease XL. 2019 (COVID-19): role of Chest CT in diagnosis and management. AJR Am J Roentgenol. 2020;4:1–7. doi:10.2214/AJR.20.22954
  • Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. 2020;295(3):715–721. doi:10.1148/radiol.202020037032053470
  • Song F, Shi N, Shan F, et al. Emerging coronavirus 2019-nCoV pneumonia. Radiology. 2020:200274. doi:10.1148/radiol.2020200274
  • Majidi H, Niksolat F. Chest CT in patients suspected of COVID-19 infection: A reliable alternative for RT-PCR. Am J Emerg Med. 2020. doi:10.1016/j.ajem.2020.04.016
  • Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131–E134. doi:10.1002/ajh.2577432129508
  • Li J, Fan JG. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. 2020;8(1):13‐17. doi:10.14218/JCTH.2020.00019
  • Chng WJ, Lai HC, Earnest A, Kuperan P. Haematological parameters in severe acute respiratory syndrome. Clin Lab Haematol. 2005;27(1):15–20. doi:10.1111/j.1365-2257.2004.00652.x15686503
  • Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;18:102763. doi:10.1016/j.ebiom.2020.102763
  • Cascella M, Rajnik M, Cuomo A, Dulebohn S, Napoli RD. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls: Treasure Island, StatPearls Publishing; 2020.
  • Rodriguez-Morales AJC-O JA, Gutiérrez-Ocampo E, Villamizar-Peña R, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Preprints. 2020:2020020378. doi:10.20944/preprints202002.0378.v3
  • Lalueza A, Ayuso B, Arrieta E, et al. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin Microbiol Infect. 2020. doi:10.1016/j.cmi.2020.02.018
  • Senjo H, Higuchi T, Okada S, Takahashi O. Hyperferritinemia: causes and significance in a general hospital. Hematology. 2018;23(10):817–822. doi:10.1080/10245332.2018.148856929914346
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa200203232109013
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
  • Lu H, Ai J, Shen Y, et al. A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention. medRxiv. 2020. doi:10.1101/2020.02.19.20025031
  • Aly MH, Rahman SS, Ahmed WA, et al. Indicators of critical illness and predictors of mortality in COVID-19 patients. Infect Drug Resist. 2020;Volume 13:1995–2000. doi:10.2147/IDR.S261159